Combination with Methotrexate and Cyclophosphamide Attenuated Maturation of Dendritic Cells: Inducing Treg Skewing and Th17 Suppression In Vivo

Table 4

BMDC surface antigen’s expression of CTX group.

Week	𝑛	BMDC surface antigen’s expression (𝑋±𝑆, %)
		CD11c	CD40	CD80	CD86	MHC-II
0	6	87.85±4.51	69.72±4.70	89.78±3.67	79.37±3.60	84.32±2.81
3	5	87.22±1.61	67.96±2.83	87.88±3.53	78.34±4.27	83.20±3.42
6	5	84.66±3.29	65.48±2.39^∗	85.36±4.21^∗	74.90±3.13^∗	79.94±4.00^∗
9	5	83.78±1.46^∗	62.92±2.08^∗#	82.70±1.66^∗#	72.00±2.45^∗#	75.32±2.09^∗#△

Values are expressed as mean ± standard deviation; the differences of BMDC surface molecules, CD40, at different time were determined by Kruskal-Wallis H test.
*Compared with 0 week, 𝑃<0.05; ^#compared with 3rd week, 𝑃<0.05; ^△compared with 6th week, 𝑃<0.05.